Faeth Therapeutics FTH
NASDAQ FTH
$32.00 -0.10 (-0.31%)
At close: Aug 21, 2026 · 4:00 PM EDT

Faeth Therapeutics (FTH) Capital Expenditures (2020 - 2026)

Faeth Therapeutics' (FTH) quarterly Capital Expenditures came in at $6000.0 in Q1 2026, down 62.5% on a QoQ basis from $16000.0 in Q2 2025.

Faeth Therapeutics (FTH) Capital Expenditures (2020 - 2026) Analysis & Trends

Faeth Therapeutics (FTH) has 7 years of Capital Expenditures data on file, last reported at $6000.0 in Q1 2026.

  • Quarterly Capital Expenditures changed N/A year-over-year to $6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22000.0 (down 79.82% YoY) and the FY2025 annual result came in at $16000.0, down 89.04% from the prior year.
  • Capital Expenditures eased to $6000.0 in Q1 2026, from $16000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $250000.0 in Q3 2022 to a low of $6000.0 in Q1 2026.
  • A 5-year average of $74333.3 and a median of $37000.0 in 2024 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2022 — Capital Expenditures tumbled 96.1% — and 2023, when it surged 694.74%.
  • Tracing FTH's Capital Expenditures over 5 years: stood at $250000.0 in 2022, then sank by 88.4% to $29000.0 in 2023, then jumped by 275.86% to $109000.0 in 2024, then slumped by 85.32% to $16000.0 in 2025, then slumped by 62.5% to $6000.0 in 2026.
  • The last three Capital Expenditures figures came in at $6000.0 (Q1 2026), $16000.0 (Q2 2025), and $109000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 25.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 34.68 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -73.57 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.26 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 251.02 Mn
10 Faeth Therapeutics 179.31 Mn 179.31 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 6,000.00
Mar 31, 2026 6,000.00
Jun 30, 2025 16,000.00
Jun 30, 2025 16,000.00
Jun 30, 2024 109,000.00
Jun 30, 2024 109,000.00
Mar 31, 2024 37,000.00
Mar 31, 2024 37,000.00
Jun 30, 2023 29,000.00
Jun 30, 2023 29,000.00
Mar 31, 2023 151,000.00
Mar 31, 2023 151,000.00
Sep 30, 2022 250,000.00
Sep 30, 2022 250,000.00
Jun 30, 2022 52,000.00
Jun 30, 2022 52,000.00
Mar 31, 2022 19,000.00
Mar 31, 2022 19,000.00
Dec 31, 2021 535,000.00
Dec 31, 2021 535,000.00